In Vitro and In Vivo Characterization of Reactive Intermediates of Corynoline
Authors:
- 1 October 2015
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 43 (10) , 1491-1498
Abstract
Corynoline is a 1,3-benzodioxole-containing isoquinoline alkaloid isolated from Corydalis bugeana Turcz., a traditional herbal medicine. Corynoline has reportedly demonstrated multiple pharmacologic properties. Previous studies have also shown that corynoline induced cytotoxicity and inhibited cytochrome P450 enzymes, but the mechanisms of the adverse effects remain unknown. The major objective of the present study was to identify reactive metabolites of corynoline responsible for the cytotoxicity and enzyme inhibition. Three oxidative metabolites (M1-M3) were detected by LC-MS/MS in rat liver microsomal incubations after exposure to corynoline. M1 and M2 were two isomers of catechol derivatives, and M3 was a di-catechol. M1-M3 were also observed in urine of rats given corynoline. A total of four N-acetylcysteine (NAC) conjugates (M4-M7) were detected in microsomes containing corynoline, NAC, and NADPH. Apparently, M4 and M5 were derived from M1, M6 resulted from M2, and M7 was a M3-derived NAC conjugate. This indicates that corynoline was bioactivated to ortho-quinone derivatives. No corynoline-derived NAC conjugates (M4-M7) were detected in urine of rats given corynoline, but three corresponding cysteinylglycine (Cys-Gly) conjugates (M8-M10) were observed instead. Recombinant P450 enzyme incubations demonstrated that CYPs 2C9, 3A4, and 2C19 were mainly involved in metabolic activation of corynoline. The metabolism study facilitates the understanding of corynoline-induced cytotoxicity and P450 enzyme inhibition.Keywords
This publication has 17 references indexed in Scilit:
- Isoquinoline alkaloids as prolyl oligopeptidase inhibitorsFitoterapia, 2015
- NIS–PPh3: A Selective Reagent for the Spiroannulation of o-Allyl Phenols. Total Synthesis of Corallidictyal DThe Journal of Organic Chemistry, 2013
- Bioactivation of Sitaxentan in Liver Microsomes, Hepatocytes, and Expressed Human P450s with Characterization of the Glutathione Conjugate by Liquid Chromatography Tandem Mass SpectrometryChemical Research in Toxicology, 2013
- Identification of cytochrome P450 (CYP) isoforms involved in the metabolism of corynoline, and assessment of its herb–drug interactionsPhytotherapy Research, 2011
- Differential Roles of Phase I and Phase II Enzymes in 3,4-Methylendioxymethamphetamine-Induced CytotoxicityDrug Metabolism and Disposition, 2010
- Assessment of the Metabolism and Intrinsic Reactivity of a Novel Catechol MetaboliteChemical Research in Toxicology, 2008
- Cytotoxic isoquinoline alkaloids from the aerial parts ofCorydalis incisaArchives of Pharmacal Research, 2007
- Inhibition of Cytochrome P450 3A4 by a Pyrimidineimidazole: Evidence for Complex Heme InteractionsChemical Research in Toxicology, 2006
- Future of ToxicologyMetabolic Activation and Drug Design: Challenges and Opportunities in Chemical ToxicologyChemical Research in Toxicology, 2006
- Minimising the potential for metabolic activation in drug discoveryExpert Opinion on Drug Metabolism & Toxicology, 2005